Evidence map›Paper›PMID 38179883›Full record

ArticleEuropean stroke journal2024

Peri-hematomal edema shape features related to 3-month outcome in acute supratentorial intracerebral hemorrhage.

Fiona Dierksen, Anh T Tran, Tal Zeevi, Ilko L Maier, Adnan I Qureshi, Pina C Sanelli, David J Werring, Ajay Malhotra, Guido J Falcone, Kevin N Sheth and 1 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in European stroke journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Fiona DierksenDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.ORCID 0009-0004-1913-0603
Anh T TranDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Tal ZeeviDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Ilko L MaierDepartment of Neurology, Georg-August University Göttingen, Göttingen, Germany.ORCID 0000-0001-6988-8878
Adnan I QureshiZeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, MO, USA.
Pina C SanelliDepartment of Feinstein Institute for Medical Research, Manhasset, NY, USA.
David J WerringStroke Research Centre, University College London, Queen Square Institute of Neurology, London, UK.
Ajay MalhotraDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Guido J FalconeDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.
Kevin N ShethDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.
Seyedmehdi PayabvashDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.
Yale University · USFeinstein Institute for Medical Research · USQueen Mary University of London · GBRehabilitation Institute of Kansas City · USUniversity of Göttingen · DE

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Lauren Ferrante · 2002 to 2026
$37.9M
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)U01NS106513 · NINDS · YALE UNIVERSITY · PI Hooman Kamel, Kevin Navin Sheth · 2019 to 2026
$20.6M
The Recovery in Stroke Using PAP (RISE UP) StudyR01NR018335 · NINR · YALE UNIVERSITY · PI REDEKER, NANCY S, SHETH, KEVIN NAVIN · 2019 to 2023
$3.4M
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)U24NS107215 · NINDS · YALE UNIVERSITY · PI MARK Jay ALBERTS, Karen L Furie · 2018 to 2026
$3.0M
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)U24NS107136 · NINDS · YALE UNIVERSITY · PI SHETH, KEVIN NAVIN, SPUDICH, SERENA S · 2018 to 2022
$1.7M
Radiomics Signatures and Patient Outcomes in Intracerebral HemorrhageK23NS118056 · NINDS · YALE UNIVERSITY · PI Seyedmehdi Payabvash · 2021 to 2026
$780k
Intensive Blood Pressure Reduction in Deep Intracerebral HemorrhageR03NS112859 · NINDS · YALE UNIVERSITY · PI FALCONE, GUIDO JOSE, SHETH, KEVIN NAVIN · 2019 to 2020
$84k
NCATS NIH HHS UL1 TR001863NIA NIH HHS K76 AG059992NIA NIH HHS P30 AG021342NINDS NIH HHS K23 NS118056NINDS NIH HHS R03 NS112859NINDS NIH HHS U01 NS106513NINDS NIH HHS U24 NS107136NINDS NIH HHS U24 NS107215NINR NIH HHS R01 NR018335
6 · The paper itself

Abstract

introductionPerihematomal edema (PHE) represents secondary brain injury and a potential treatment target in intracerebral hemorrhage (ICH). However, studies differ on optimal PHE volume metrics as prognostic factor(s) after spontaneous, non-traumatic ICH. This study examines associations of baseline and 24-h PHE shape features with 3-month outcomes. PATIENTS AND

methodsWe included 796 patients from a multicentric trial dataset and manually segmented ICH and PHE on baseline and follow-up CTs, extracting 14 shape features. We explored the association of baseline, follow-up, difference (baseline/follow-up) and temporal rate (difference/time gap) of PHE shape changes with 3-month modified Rankin Score (mRS) - using Spearman correlation. Then, using multivariable analysis, we determined if PHE shape features independently predict outcome adjusting for patients' age, sex, NIH stroke scale (NIHSS), Glasgow Coma Scale (GCS), and hematoma volume.

resultsBaseline PHE maximum diameters across various planes, main axes, volume, surface, and sphericity correlated with 3-month mRS adjusting for multiple comparisons. The 24-h difference and temporal change rates of these features had significant association with outcome - but not the 24-h absolute values. In multivariable regression, baseline PHE shape sphericity (OR = 2.04, CI = 1.71-2.43) and volume (OR = 0.99, CI = 0. 98-1.0), alongside admission NIHSS (OR = 0.86, CI = 0.83-0.88), hematoma volume (OR = 0.99, CI = 0. 99-1.0), and age (OR = 0.96, CI = 0.95-0.97) were independent predictors of favorable outcomes.

conclusionIn acute ICH patients, PHE shape sphericity at baseline emerged as an independent prognostic factor, with a less spherical (more irregular) shape associated with worse outcome. The PHE shape features absolute values over the first 24 h provide no added prognostic value to baseline metrics.

Indexed as

Brain EdemaCerebral HemorrhageAgedFemaleGlasgow Coma ScaleHematomaHumansMaleMiddle AgedPrognosisTomography, X-Ray Computedhemorrhagic strokeIntracerebral hemorrhageperihematomal edemasphericity

Identifiers

PMID38179883
PMCPMC11318427
OpenAlexW4390614288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.